Plasma leptin and neuropeptide Y concentrations in patients with rheumatoid arthritis treated with infliximab, a TNF-α antagonist

Rheumatology International

Volumn 32, Issue 11, 2012, Pages 3383-3389

  Kopec Medrek, Magdalena ^a   Kotulska, Anna ^a   Widuchowska, Malgorzata ^a   Adamczak, Marcin ^a   Więcek, Andrzej ^a   Kucharz, Eugene J ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

Body mass; Infliximab; Leptin; Neuropeptide Y; Rheumatoid arthritis

Indexed keywords

C REACTIVE PROTEIN; INFLIXIMAB; LEPTIN; METHOTREXATE; NEUROPEPTIDE Y; PREDNISONE;

ARTICLE; BLOOD SAMPLING; BODY FAT; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE ASSOCIATION; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HORMONE RELEASE; HUMAN; HUMAN TISSUE; LEAN BODY WEIGHT; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RHEUMATOID ARTHRITIS; WAIST HIP RATIO;

EID: 84872174783     PISSN: 01728172     EISSN: 1437160X     Source Type: Journal    
DOI: 10.1007/s00296-011-2182-6     Document Type: Article

References (31)

1. Jeanrenaud B, Rohner-Jeanrenaud F (2001) Effects of neuropeptides and leptin on nutrient partitioning: dysregulation in obesity. Annu Rev Med 52:339-351 (Pubitemid 32195329)
2. Lago R, Gómez R, Lago F, Gómez-Reino J, Gualillo O (2008) Leptin beyond body weight regulation-current concepts concerning its role in immune function and inflammation. Cell Immunol 252:139-145
3. Huang Q, Viale A, Picard F, Nahon J, Richard D (1999) Effects of leptin on melanin concentrating hormone expression in the brain of lean ad obese Lep(ob)/lep(ob) mice. Neuroendocrinology 69:145-153 (Pubitemid 29134489)
4. Nowak KW, Maćkowiak P, S ́ witońska MM, Fabis M, Malendowicz LK (2000) Acute orexin effects on insulin secretion in the rat: in vivo and in vitro studies. Life Sci 66:449-454 (Pubitemid 30025501)
5. Ollmann MM, Wilson BD, Yang YK, Kerns JA, Chen Y, Gantz I, Barsh GS (1997) Antagonism of central melanocortin receptors in vitro and in vivo by agouti-related protein. Science 278: 135-138 (Pubitemid 27446294)
6. Richard D, Rivest R, Naimi N, Timofeeva E, Rivest S (1996) Expression of corticotropin-releasing factor and its receptors in the brain of lean and obese Zucker rats. Endocrinology 137:4786-4795 (Pubitemid 26403320)
7. Goldstone AP, Mercer JG, Gunn I, Moar KM, Edwards CMB, Rossi M, Howard JK, Rasheed S, Turton MD, Small C, Heoth MM, O'Shea D, Steere J, Meeran K, Ghatei MA, Hoggard N, Bloom SR (1997) Leptin interacts with glucagon-like peptide-1 neurons to reduce food intake and body weight in rodents. FEBS Lett 415:134-138 (Pubitemid 27430055)
8. Ebihara K, Ogawa Y, Katsuura G, Numata Y, Masuzaki H, Satoh N, Tamaki M, Yoshioka T, Hayse M, Matsuoka N, Aizova-Abe M (1999) Involvement of agouti-related protein, an endogenous antagonist of hypothalamic melanocortin receptor, in leptin action. Diabetes 48:2028-2033 (Pubitemid 29458367)
9. Shimabukuro M, Koyama K, Chen G, Wang MY, Trien F, Lee Y, Newgard CB, Unger RH (1997) Direct antidiabetic effect of leptin through triglyceride depletion of tissues. Proc Natl Acad Sci USA 94:4637-4641 (Pubitemid 27194295)
10. Reidy H, Furst P (1997) Decreased white fat cell thermogenesis in obese individuals. Int J Obes 21:439
11. Considine RV, Sinha MK, Heiman ML, Kriauciunas A, Stephans TW, Nyce MR, Ohannesian JP, Marco CC, Mc Kee LJ, Bauer TL (1996) Serum immunoreactive leptin concentrations in normal weight and obese humans. N Engl J Med 334: 292-295 (Pubitemid 26033933)
12. Ongphiphadhanakaul B, Rajatanavin R, Chanpraserthyothin S, Piaseu N, Chailurkit L (1999) Serum leptin concentration in relation to body fat, gender, sex hormones and metabolic covariates in Thai. J Med Assoc Thai 82:862-867
13. Ambrosius WT, Compton JA, Bowsher RR, Pratt H (1998) Relation of race, age and hormone differences to serum leptin concentrations in children and adolescents. Horm Res 49:240-246 (Pubitemid 28165742)
14. Grunfeld C, Zhao C, Fuller J, Pollack A, Moser A, Fridman J, Feingold KR (1996) Endotoxin and cytokines induce expression of leptin, the ob gene product, in hamsters. J Clin Invest 97:2152-2157
15. Fraker DL, Stovroff MC, Merino MJ, Norton JA (1988) Tolerance to tumor necrosis factor in rats and the relationship to endotoxin tolerance and toxicity. J Exp Med 168:95-105
16. Tracey KJ, Wei H, Manogue KR, Fong Y, Hesse DG, Nguyen HT, Kuo GC, Beuhler B, Cotran RS, Cerami A, Lowry SF (1988) Cachectin/tumor necrosis factor induces cachexia, anemia, and inflammation. J Exp Med 167:1211-1227
17. Gelin J, Moldawer LL, Lonnorth C, Sherry B, Chizzonite R, Lundholm K (1991) Role of endogenous tumor necrosis factor a and interleukin 1 for experimental tumor growth and the development of cancer cachexia. Cancer Res 51:415-421
18. Sherry BA, Gelin J, Fong Y, Marano M, Wei H, Cerami A, Lowry SF, Lundholm KG, Moldawer LL (1989) Anticachectin/ tumor necrosis factor-A antibodies attenuate development of cachexia in tumor models. FASEB J 3:1956-1962 (Pubitemid 19152583)
19. Knight DM, Trinh H, Le J, Siegel J, Shealy D, Mc Donough M, Scallan B, Moore MA, Vilcek J, Daddona P (1993) Construction and initial characterization of a mouse-human chimeric anti-TNF antibody. Mol Immunol 30:1443-1453
20. Nishiya K, Nishiyama M, Chang A, Shinto A, Hashimoto K (2002) Serum leptin level in patients with rheumatoid arthritis are correlated with body mass index. Rinsho-Byori 50:524-527
21. Popa C, Netea MG, Barrera P, Van Riel PL, Van der Meer JWM (2004) Chronic inflammation lowers plasma leptin concentrations in patients with rheumatoid arthritis. Ann Rheum Dis 63(Suppl 1):136
22. Popa C, Netea MG, de Graff J et al (2009) Circulating leptin and adiponectin concentrations during tumor necrosis factor blockade in patients with active rheumatoid arthritis. J Rheumatol 36:724-730
23. Anders HJ, Rihl M, Heufelder A, Loch O, Schattenkirchner M (1999) Leptin serum levels are not correlated with disease activity in patients with rheumatoid arthritis. Metabolism 48:745-748 (Pubitemid 29277646)
24. Tokarczyk-Knapik A, Nowicki M, Wyroślak J (2002) The relation between plasma leptin concentration and body fat mass in patients with rheumatoid arthritis. Pol Arch Med Wew 108:761-767
25. Otero M, Lago R, Gomez R, Lago F et al (2006) Changes in plasma levels of fat-derived hormones adiponectin, leptin, resistin and visfatin in patients with rheumatoid arthritis. Ann Rheum Dis 65:1198-1201 (Pubitemid 44277396)
26. Gonzalez-Gay MA, Garcia-Unzueta MT, Berja A et al (2009) Anti-TNF-A therapy does not modulate leptin in patients with severe rheumatoid arthritis. Clin Exp Rheumatol 27:222-228
27. van Gossum A, Roland S, Vermeire S, Quertinmont E, Gustot T, Gervy C, Deviere J, Franchimont D (2003) Impact of infliximab on weight regulation and lipid metabolism: immuno-neutralization of TNF-A induced leptinemia in Crohn's disease. Clin Nutr 22(S1): S51
28. Zhang HH, Kumar S, Barnett AH, Eggo MC (2000) Tumor necrosis factor: a exerts dual effects on human adipose leptin synthesis and release. Mol Cell Endocrinol 159:79-88 (Pubitemid 30067642)
29. Granowitz EV (1997) Transforming growth factor-beta enhances and proinflammatory cytokines inhibit ob gene expression in 3T3-L adipocytes. Biochem Biophys Res Commun 240:382-385
30. Dekkers JC, Geenen R, Godaert GL, Bijlsama JW, van Doornen LJ (2004) Elevated sympathetic nervous system activity in patients with recently diagnosed rheumatoid arthritis with active disease. Clin Exp Rheumatol 22:63-70 (Pubitemid 38236126)
31. Targońska-Stepniak B, Majdan M, Dryglewska M (2007) Leptin serum levels in rheumatoid arthritis patients: relation to disease duration and activity. Rheumatol Int 28:585-591